What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary

J Musculoskelet Neuronal Interact. 2022 Mar 1;22(1):1-4.
No abstract available

Keywords: Anti-Osteoporotic Drugs; Chronic Kidney Disease; Fragility Fractures; Osteoporosis; Rehabilitation.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Male
  • Osteoporosis* / complications
  • Osteoporosis* / drug therapy
  • Osteoporotic Fractures* / therapy
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / drug therapy